BioPlus Acquisition Corp.
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on $5,163,060 over the previous period. Total operating expenses were $1,171,196.

Profit Margin

BioPlus Acquisition Corp. (NASDAQ:BIOSW): Profit margin
2013 842.2M -53.6M -6.36%
2014 984.1M -143.4M -14.57%
2015 982.2M -303.5M -30.9%
2016 935.6M -34.4M -3.68%
2017 817.2M -131M -16.03%
2018 708.9M -51.6M -7.28%
2021 0 -152
2022 0 5.16M

BIOSW Income Statement (2013 – 2022)

2022 2021 2018 2017 2016 2015 2014 2013
Revenue
Revenue
00708.9M817.2M935.6M982.2M984.1M842.2M
Cost of revenue
1.17M0465.9M547.9M670M721.3M723M570.4M
Gross profit
-1.17M0243M269.3M265.6M260.9M261.1M271.8M
Operating exp.
Research and development
00000000
Selling and marketing
00000000
Total operating expenses
1.17M162236.89M284.1M263.7M548.6M354.5M294.7M
Operating income
-1.17M-162-108.5M-52.7M-77.7M-358.5M-93.5M-22.9M
Other income (expenses), net
3.16M957.5M-14.7M45.3M33.5M-38.5M-28.2M
Income before tax
1.99M-152-51M-67.4M-32.4M-325M-132M-51.1M
Income tax expense
-3.16M9600K63.6M2M-21.5M11.4M2.5M
Net income
5.16M-152-51.6M-131M-34.4M-303.5M-143.4M-53.6M
Earnings per share
Basic EPS
0.00-0.02-0.4-1.06-0.37-4.42-2.09-0.83
Diluted EPS
0.00-0.02-0.4-1.06-0.37-4.42-2.09-0.83
Data sourceData source